speb/financial-data huggingface dataset:
MDNA.TO cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -33000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MDNA.TO cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -16492000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -4996000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 1523000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1252000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Change In Receivables: -209000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -289000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Change In Working Capital: 1314000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 963000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Changes In Cash: 6967000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -5015000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Common Stock: 116297000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 116297000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Common Stock Equity: 19095000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 19095000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Common Stock Issuance: 19714000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 1685000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1685000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Current Assets: 28171000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 28171000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 49000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 49000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 49000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 49000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Current Liabilities: 4435000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4435000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Depreciation: 53000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 19000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 53000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 19000.00
MDNA.TO income_statement (annual, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 55000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 19000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 53000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 19000.00
MDNA.TO income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 55000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 19000.00
MDNA.TO income_statement (annual, 2025-03-31) — Depreciation Income Statement: 55000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 19000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 4733000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 4733000.00
MDNA.TO income_statement (annual, 2025-03-31) — Diluted Average Shares: 76671175.00
MDNA.TO income_statement (annual, 2025-03-31) — Diluted EPS: -0.15
MDNA.TO income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — EBIT: -20406000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — EBIT: -5719000.00
MDNA.TO income_statement (annual, 2025-03-31) — EBITDA: -20351000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — EBITDA: -5700000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 888000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -144000.00
MDNA.TO cash_flow (annual, 2025-03-31) — End Cash Position: 24837000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 24837000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Financing Cash Flow: 23492000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -19000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Free Cash Flow: -16525000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -4996000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -6347000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -6747000.00
MDNA.TO income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 7251000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 6642000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3000.00
MDNA.TO income_statement (annual, 2025-03-31) — General And Administrative Expense: 5907000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1206000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 52000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 52000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Gross PPE: 159000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 159000.00
MDNA.TO income_statement (annual, 2025-03-31) — Interest Income: 1350000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Interest Income: 264000.00
MDNA.TO income_statement (annual, 2025-03-31) — Interest Income Non Operating: 1350000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 264000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Invested Capital: 19095000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19095000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Investing Cash Flow: -33000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
MDNA.TO cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 19714000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 119000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 119000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 119000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 119000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -19000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 19714000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
MDNA.TO cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -904000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 105000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Income: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Income: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1187000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -11805000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1187000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Interest Income: 1350000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 264000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -19000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -19000.00
MDNA.TO income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 1350000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 264000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Net PPE: 159000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 159000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -33000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 19043000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 19043000.00
MDNA.TO income_statement (annual, 2025-03-31) — Normalized EBITDA: -27602000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -12342000.00
MDNA.TO income_statement (annual, 2025-03-31) — Normalized Income: -19056000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -4458700.00
MDNA.TO cash_flow (annual, 2025-03-31) — Operating Cash Flow: -16492000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -4996000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Operating Gains Losses: -7251000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -6642000.00
MDNA.TO income_statement (annual, 2025-03-31) — Operating Income: -20406000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Operating Income: -5719000.00
MDNA.TO income_statement (annual, 2025-03-31) — Operating Revenue: 0.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 78215735.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 78215735.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 3000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 3000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Other Equity Interest: 9831000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 9831000.00
MDNA.TO income_statement (annual, 2025-03-31) — Other Gand A: 2878000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 662000.00
MDNA.TO income_statement (annual, 2025-03-31) — Other Income Expense: 7251000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 6642000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Other Non Cash Items: -1017000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1019000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Other Properties: 18000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 18000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Payables: 2701000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Payables: 2701000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 4386000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 4386000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Prepaid Assets: 639000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 639000.00
MDNA.TO income_statement (annual, 2025-03-31) — Pretax Income: -11805000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 1187000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Proceeds From Stock Option Exercised: 3797000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Properties: 0.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MDNA.TO cash_flow (annual, 2025-03-31) — Purchase Of PPE: -33000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Receivables: 2695000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 2695000.00
MDNA.TO income_statement (annual, 2025-03-31) — Reconciled Depreciation: 53000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 19000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Repayment Of Debt: -19000.00
MDNA.TO income_statement (annual, 2025-03-31) — Research And Development: 14444000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Research And Development: 4494000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Retained Earnings: -118252000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -118252000.00
MDNA.TO income_statement (annual, 2025-03-31) — Salaries And Wages: 3029000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 544000.00
MDNA.TO income_statement (annual, 2025-03-31) — Selling General And Administration: 5907000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1206000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Share Issued: 78215735.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 78215735.00
MDNA.TO cash_flow (annual, 2025-03-31) — Stock Based Compensation: 2214000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 496000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Stockholders Equity: 19095000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 19095000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Tangible Book Value: 19043000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 19043000.00
MDNA.TO income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 996300.00
MDNA.TO income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
MDNA.TO balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2695000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2695000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Assets: 28382000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 28382000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Capitalization: 19095000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19095000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Debt: 168000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 168000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 19095000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 19095000.00
MDNA.TO income_statement (annual, 2025-03-31) — Total Expenses: 20406000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 5719000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 9287000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 9287000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 211000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 211000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4852000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4852000.00
MDNA.TO income_statement (annual, 2025-03-31) — Total Unusual Items: 7251000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 6642000.00
MDNA.TO income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 7251000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 6642000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Working Capital: 23736000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 23736000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 5509000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3187000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 11558000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 82524834.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.06
MDNA.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 24837000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 128000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 162000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 126228000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 20459000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 20459000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 13969000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 6490000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 39000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3546000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 128000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1215000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1343000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3507000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 126228000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 14641000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1327000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 22578000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 58000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 58000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4572000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 19000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 19000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 19000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 19000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 19000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 19000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 3453000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 82524834.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.06
MDNA.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — EBIT: -5509000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — EBITDA: -5490000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -871000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 20459000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 39000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3546000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -1280000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 377000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 35000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1283000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 50000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 142000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Interest Income: 204000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 204000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 14641000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 104000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 104000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -13000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 903000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Income: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4928000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4928000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 204000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -13000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -13000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 204000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 142000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 14591000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -5867000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -5305000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3546000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -377000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Operating Income: -5509000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 83380720.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 35000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 730000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 377000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 7000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 14000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Payables: 3187000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4514000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 947000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -4928000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 52000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 1172000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 19000.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -13000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Research And Development: 4207000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -123180000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 553000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1283000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 83380720.00
MDNA.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 390000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 14641000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 14591000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1172000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 22770000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 14641000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 162000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 14641000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 5509000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8129000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 192000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3557000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 377000.00
MDNA.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 377000.00
MDNA.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 18006000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 5470000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3646000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 12013000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 83408288.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.06
MDNA.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 20459000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 115000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 149000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 126241000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 15748000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 15748000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 8846000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6902000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -19000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -4937000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -117000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -5000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -122000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -4956000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 126241000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10242000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 751000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 17872000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 62000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 62000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4459000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 23000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 23000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 19000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 23000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 19000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 19000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 3253000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 83408288.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.06
MDNA.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — EBIT: -5470000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — EBITDA: -5447000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 245000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 15748000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -19000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -4937000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -200000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 429000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 51000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1344000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 49000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 120000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Interest Income: 158000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 158000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 10242000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 87000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 87000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -19000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -229000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Income: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -4883000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -4883000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 158000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -19000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -19000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 158000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 120000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10193000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -5876000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -5312000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -4937000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -429000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Operating Income: -5470000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 83411435.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 51000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 772000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 429000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 6000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 5000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Payables: 3646000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4397000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 861000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -4883000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 1261000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 23000.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -19000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Research And Development: 4107000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -128063000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 572000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1344000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 83411435.00
MDNA.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 468000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10242000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 10193000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 1261000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 18041000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 10242000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 149000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10242000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 5470000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7799000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 169000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3340000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 429000.00
MDNA.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 429000.00
MDNA.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 13413000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 5616000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4252000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 12328000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 83415481.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.05
MDNA.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 15748000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 101000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 135000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 126257000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 10614000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10614000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 8862000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1752000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -19000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4965000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 361000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -176000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 185000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4982000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 126257000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6212000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 506000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 12914000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 65000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 65000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4823000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 16000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 16000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 19000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 16000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 19000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 19000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 1960000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 83415481.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.05
MDNA.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — EBIT: -5616000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — EBITDA: -5597000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -152000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 10614000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -19000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4965000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1293000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1138000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 54000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1524000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 48000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 103000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Interest Income: 114000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 114000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6212000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 2000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 70000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 70000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -19000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 155000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Income: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4364000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -4364000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 114000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -19000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -19000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 114000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 103000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 2000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6164000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -6735000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -5502000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4965000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1138000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Operating Income: -5616000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 83420201.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 54000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 904000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 1138000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 5000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 2000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Payables: 4252000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4758000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 835000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -4364000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 1465000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 16000.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -19000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Research And Development: 4073000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -132427000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 620000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1524000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 83420201.00
MDNA.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 331000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6212000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6164000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1465000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 13065000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6212000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 135000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6212000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 5616000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6853000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 151000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2030000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 1138000.00
MDNA.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1138000.00
MDNA.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 8091000.00
MDNA.TO income_statement (annual, 2026-03-31) — +Operating Expense: 22417000.00
MDNA.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 5822000.00
MDNA.TO income_statement (annual, 2026-03-31) — +Total Revenue: 0.00
MDNA.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Accounts Payable: 4848000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4848000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 12728000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 12728000.00
MDNA.TO cash_flow (annual, 2026-03-31) — Beginning Cash Position: 24837000.00
MDNA.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 10614000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 88000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 88000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 119000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 119000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Capital Stock: 126257000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 126257000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 6251000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6251000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6251000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6251000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Cash Equivalents: 3384000.00
MDNA.TO balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 3384000.00
MDNA.TO balance_sheet (annual, 2026-03-31) — Cash Financial: 2867000.00